These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11070352)

  • 1. Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line.
    Joly-Pharaboz MO; Ruffion A; Roch A; Michel-Calemard L; André J; Chantepie J; Nicolas B; Panaye G
    J Steroid Biochem Mol Biol; 2000; 73(5):237-49. PubMed ID: 11070352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
    Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
    J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
    Berns EM; de Boer W; Mulder E
    Prostate; 1986; 9(3):247-59. PubMed ID: 2946029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.
    Soto AM; Lin TM; Sakabe K; Olea N; Damassa DA; Sonnenschein C
    Oncol Res; 1995; 7(10-11):545-58. PubMed ID: 8866667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen inhibits the growth of carcinoma cell lines established from prostate cancer xenografts that escape androgen treatment.
    Joly-Pharaboz MO; Kalach JJ; Pharaboz J; Chantepie J; Nicolas B; Baille ML; Ruffion A; Benahmed M; André J
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):50-9. PubMed ID: 18550362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of the proliferation of prostate cancer cells by an androgen and two antiandrogens. Cell specific sets of responses.
    Foury O; Nicolas B; Joly-Pharaboz MO; André J
    J Steroid Biochem Mol Biol; 1998 Aug; 66(4):235-40. PubMed ID: 9744520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
    Lyng FM; Jones GR; Rommerts FF
    Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
    Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.
    Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ
    Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
    Chen F; Knecht K; Leu C; Rutledge SJ; Scafonas A; Gambone C; Vogel R; Zhang H; Kasparcova V; Bai C; Harada S; Schmidt A; Reszka A; Freedman L
    J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):247-57. PubMed ID: 15336702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
    Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM
    Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
    Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
    Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride.
    Umekita Y; Hiipakka RA; Kokontis JM; Liao S
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11802-7. PubMed ID: 8876218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line.
    Cinar B; Koeneman KS; Edlund M; Prins GS; Zhau HE; Chung LW
    Cancer Res; 2001 Oct; 61(19):7310-7. PubMed ID: 11585771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
    Cleutjens KB; van der Korput HA; van Eekelen CC; van Rooij HC; Faber PW; Trapman J
    Mol Endocrinol; 1997 Feb; 11(2):148-61. PubMed ID: 9013762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen blocks apoptosis of hormone-dependent prostate cancer cells.
    Kimura K; Markowski M; Bowen C; Gelmann EP
    Cancer Res; 2001 Jul; 61(14):5611-8. PubMed ID: 11454715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
    Schatten H; Ripple M; Balczon R; Weindruch R; Chakrabarti A; Taylor M; Hueser CN
    J Cell Biochem; 2000 Jan; 76(3):463-77. PubMed ID: 10649443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP.
    Swinnen JV; Van Veldhoven PP; Esquenet M; Heyns W; Verhoeven G
    Endocrinology; 1996 Oct; 137(10):4468-74. PubMed ID: 8828509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.